Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 204.80
+2.20 (1.09%)
Aug 11, 2026, 1:15 PM HKT
HKG:2637 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HKG:2637 stock has a consensus rating of "Strong Buy" and an average price target of $291.55. The average 1-year stock price forecast is 42.36% higher than the current stock price, while the lowest is $281.11 (+37.26%) and the highest is $301.98 (+47.45%).
Price Target: $291.55 (+42.36%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jul 3, 2026.
Analyst Ratings
The average analyst rating for HKG:2637 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $298.99 | Buy | Maintains | $298.99 | +45.99% | Jul 3, 2026 |
Unknown Analyst Huafu Securities No rating | Huafu Securities | Buy Maintains $264.30 | Buy | Maintains | $264.30 | +29.05% | Jun 14, 2026 |
| CMB International Securities | CMB International Securities | Buy Initiates $280.00 | Buy | Initiates | $280.00 | +36.72% | Jun 10, 2026 |
Unknown Analyst Northeast Securities No rating | Northeast Securities | Buy Maintains $346.75 | Buy | Maintains | $346.75 | +69.31% | May 8, 2026 |
Unknown Analyst Guohai Securities No rating | Guohai Securities | Buy Maintains $339.55 | Buy | Maintains | $339.55 | +65.80% | May 7, 2026 |
Financial Forecast
Revenue This Year
722.00M
from 582.36M
Increased by 23.98%
Revenue Next Year
850.00M
from 722.00M
Increased by 17.73%
EPS This Year
2.53
EPS Next Year
2.94
from 2.53
Increased by 16.21%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.